Therapeutics for type-2 diabetes mellitus: a glance at the recent inclusions and novel agents under development for use in clinical practice

Diabetes mellitus (DM) is a chronic, progressive, and multifaceted illness resulting in significant physical and psychological detriment to patients. As of 2019, 463 million people are estimated to be living with DM worldwide, out of which 90% have type-2 diabetes mellitus (T2DM). Over the years, si...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Najeeb, Abdalla, Mohammed Altigani, Deshmukh, Harshal, Sathyapalan, Thozhukat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474306/
https://www.ncbi.nlm.nih.gov/pubmed/34589201
http://dx.doi.org/10.1177/20420188211042145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474306/
https://www.ncbi.nlm.nih.gov/pubmed/34589201
http://dx.doi.org/10.1177/20420188211042145

Ejemplares similares